Implantable lead and method for stimulating the vagus nerve
First Claim
1. A method for controlling a patient'"'"'s heart rate, comprising:
- positioning a vagal electrode proximate to the patient'"'"'s right vagus nerve near the patient'"'"'s cardiac branch;
positioning an atrial electrode in the patient'"'"'s atrium;
detecting the patient'"'"'s atrial rate; and
delivering stimulation pulses to the vagal electrode when a fast atrial rate is detected, the stimulation pulses being delivered at a level that reduces the atrial rate to a normal operating range.
1 Assignment
0 Petitions
Accused Products
Abstract
Methods and apparatus for stimulating the right vagal nerve within a living body via positioning an electrode portion of a lead proximate to the portion of the vagus nerve where the right cardiac branch is located (e.g., near or within an azygos vein, or the superior vena cava near the opening of the azygos vein) and delivering an electrical signal to an electrode portion adapted to be implanted therein. Stimulation of the right vagus nerve and/or the cardiac branch thereof act to slow the atrial heart rate. Exemplary embodiments include deploying an expandable or self-oriented electrode (e.g., a basket, an electrode umbrella, and/or an electrode spiral electrode, electrode pairs, etc). Various dedicated and single-pass leads are disclosed, as well as, various electrodes, and stabilization means. The methods include preserving sinus rhythm, avoiding asystole, preserving A-V synchrony, automatically determining parameter combinations that achieve these features, and further (in one embodiment) automatically determining parameter combinations achieve these features and reduce current drain.
409 Citations
33 Claims
-
1. A method for controlling a patient'"'"'s heart rate, comprising:
-
positioning a vagal electrode proximate to the patient'"'"'s right vagus nerve near the patient'"'"'s cardiac branch;
positioning an atrial electrode in the patient'"'"'s atrium;
detecting the patient'"'"'s atrial rate; and
delivering stimulation pulses to the vagal electrode when a fast atrial rate is detected, the stimulation pulses being delivered at a level that reduces the atrial rate to a normal operating range. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15)
-
-
16. An implantable stimulation lead for enhancing a patient'"'"'s vagal tone, comprising:
-
a transvenous lead body having an insulating sheath surrounding at least one conductor, the at least one conductor being coupled to at least one proximal connector; and
an electrode portion, coupled to the conductor, configured to be positioned within a patient'"'"'s azygos vein and dimensioned to make contact with tissue proximate to the cardiac branch of the right vagus nerve. - View Dependent Claims (17, 18, 19, 20, 21, 22, 23, 24, 25, 26)
-
-
27. An implantable single-pass stimulation lead for controlling a patient'"'"'s atrial rate, comprising:
-
a transvenous lead body having an insulating sheath having first and second conductors, the first and second conductors being electrically isolated and coupled to first and second proximal terminals;
an atrial electrode, coupled to the first conductor, and configured on the lead body so as to be capable of sensing atrial signals; and
an electrode portion, coupled to the second conductor, configured to be positioned within a patient'"'"'s superior vena cava (SVC) and dimensioned to make contact with tissue proximate to the cardiac branch of the right vagus nerve. - View Dependent Claims (28, 29, 30, 31, 32, 33)
-
Specification